Page last updated: 2024-08-16

zaleplon and pregabalin

zaleplon has been researched along with pregabalin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Annand, F; Burkinshaw, P; Carville, S; Eastwood, B; Greaves, F; Kelleher, M; Knight, J; Marsden, J; O'Connor, R; Taylor, S; Tran, A; White, M; Willey, P1

Reviews

2 review(s) available for zaleplon and pregabalin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.
    The lancet. Psychiatry, 2019, Volume: 6, Issue:11

    Topics: Acetamides; Adolescent; Adult; Aged; Analgesics; Analgesics, Opioid; Antidepressive Agents; Azabicyclo Compounds; Benzodiazepines; Databases, Factual; England; Female; Gabapentin; Humans; Hypnotics and Sedatives; Male; Middle Aged; Piperazines; Pregabalin; Public Health; Pyrimidines; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult; Zolpidem

2019

Other Studies

1 other study(ies) available for zaleplon and pregabalin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013